ELVN
Enliven Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:39:04 AM EST
45.63USD+1.648%(+0.74)10,679
ELVN News
Enliven Therapeutics GAAP EPS of -$0.36 ·
Seeking Alpha
Enliven Therapeutics CFO Hohl sells $231,545 in shares ·
Investing.com
Enliven Therapeutics CMO Collins sells $192,342 in ELVN stock ·
Investing.com
H.C. Wainwright raises Enliven Therapeutics price target to $73 ·
Investing.com
Enliven Therapeutics appoints Kristine Ball to board ·
Investing.com
Enliven Therapeutics director Scott Garland sells $606k in stock ·
Investing.com
FDA agrees ENABLE-2 Phase III trial design for Enliven’s relcobatinib ·
Clinical Trials Arena
These ten healthcare stocks posted the biggest one-month losses ·
Seeking Alpha